...ilable antibiotic therapy for treating H. pylori infection has multiple disadvantages. Thus, development of a new, more efficient antimicrobial therapeutic agent against H. pylori is a necessity. The University of Novi Sad, Faculty of Sciences, and the Hungarian Academy of Sciences, Biological Research Centre, developed a joint initiative to bring Serbian and Hungarian researchers together with th ...